Act Now to Save on SOTA Registration

There are only a few days left to save on registration for the 35th Annual State-of-the-Art Echocardiography™. Register by Tuesday, January 17, 2023, and save $100!

Join outstanding faculty in sunny Scottsdale, Arizona, and learn the latest on structural heart disease, myocardial and pericardial disease, coronary artery disease, interventional echocardiography, and more! Act fast if you’re interested in participating in the optional preconference Learning Lab (separate fee required). Limited registration spots remain for these intimate sessions!

A total of 31.75 AMA PRA Category 1 credits(pending approval) will be offered for the preconference Learning Lab (15 credits) and main course (16.75 credits). In addition to offering CME credits, this activity has been developed and registered with ACCME to provide MOC, MOC Part 2, and MOCA 2.0 credits in alignment with AMA PRA Category 1 Credit™.

Finally, after registering, we encourage you to book your hotel reservation with the Westin Kierland as soon as possible. The hotel room block will be held until Monday, January 16, 2023, but we expect it will sell out soon. This is a beautiful property offering golf, tennis, pools, and a spa onsite.

January 2023 JASE now available

The role of echocardiography in detection and evaluation of valvular heart disease is a focus topic of the January 2023 JASE, now online. This issue also includes ASE’s newest guideline, “Recommendations for the Use of Echocardiography in the Evaluation of Rheumatic Heart Disease,” from Pandian et al.

January 2023 JASE

Patricia A. Pellikka, MD, FASE, who begins her tenure as JASE Editor-in-Chief with this first issue of 2023, said that she chose the focus topic to coincide with the publication of the guideline, putting out a call for papers last summer. Read Dr. Pellikka’s first Editor’s page, which offers insights on several of the clinical investigations. Editorials, brief research communications, and correspondence in this issue also provide further insights on echocardiography in valvular heart disease. The guideline is the January CME article.

The President’s Message from Stephen H. Little, MD, FASE, shares the history of ASE’s Leadership Academy, which was developed by the Governance Committee “to provide a way to engage our early and mid-career members to develop their leadership skills.” If you missed the prior announcement of those who were recently accepted into the third cohort of the LA, meet them in his message! The continuing education and meeting calendar outlines a multitude of learning options near and far.

ASE Releases Updated Rheumatic Heart Disease Guideline

FOR IMMEDIATE RELEASE

Contact: Angie Porter
919-297-7152
aporter@ASEcho.org

American Society of Echocardiography Releases Updated Rheumatic Heart Disease Guideline

The guideline focuses on the use of echocardiography in the evaluation and management

of patients with Rheumatic Heart Disease

(DURHAM, NC, Jan. 4, 2023)—Acute rheumatic fever and rheumatic heart disease (RHD) pose major health problems globally and remain the most common cardiovascular disease in children and young people worldwide. Echocardiography is the most important diagnostic tool in recognizing this preventable and treatable disease. It plays an invaluable role in detecting the presence of subclinical disease and assessing the need for prompt therapy or follow-up evaluation.

The American Society of Echocardiography (ASE) released a new guideline document, Recommendations for the Use of Echocardiography in the Evaluation of Rheumatic Heart Disease: A Report from the American Society of Echocardiography, which provides recommendations for the comprehensive use of echocardiography in the diagnosis and therapeutic intervention of RHD. This document was endorsed by 25 ASE International Alliance Partners and is published in the January 2023 issue of the Journal of the American Society of Echocardiography.

The document is an update to previous guideline documents originally published in 2007 and 2009 that focused on valvular stenosis or valvular regurgitation etiology. This new guideline is the first document that addresses all cardiac abnormalities caused by RHD.

ASE’s lead author Natesa G. Pandian, MD, FACC, explained echocardiography is indispensable in managing the disease, and it is important for physicians to learn and teach how to apply echocardiography in the evaluation of RHD to treat patients.

“RHD is a global and regional burden in both economically constrained and advanced countries. The disease can evolve anywhere where there is a lack of sanitary conditions, access to primary care and health education,” he said. “It starts with a sore throat and fever, and if it is not recognized as a Streptococcal infection and treated, it can go on to cause rheumatic fever, cardiac inflammation, and chronic heart disease with a spectrum of debilitating lesions. Often, chronic lesions are recognized late because of slowly evolving symptoms. Echocardiography, with its multifaceted imaging approach, plays a critical role in the diagnosis, assessment of severity, detection of complications and in guiding therapy.”

This document and all guidelines published by ASE are available at ASEcho.org/Guidelines.

About American Society of Echocardiography
The American Society of Echocardiography (ASE) is the Society for Cardiovascular Ultrasound Professionals™. ASE is the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, veterinarians, and scientists and as such is the leader and advocate, setting practice standards and guidelines for the field. The Society is committed to advancing cardiovascular ultrasound to improve lives. For more information, visit the ASE website ASEcho.org or social media pages on Facebook, Twitter, LinkedIn, or Instagram.

###

PDF of news release

ASE Partners with Preventative Cardiovascular Nurses Association (PCNA)

ASE is partnering with Preventive Cardiovascular Nurses Association (PCNA) to present education on topics that touch echocardiographers and the cardiovascular nursing team. The goal of this partnership is to share learning, perspectives, and communicate the challenges and opportunities around patient identification and management that impact both communities.

Sharing expertise across team members can provide each member with a deeper understanding of issues in various cardiovascular diseases. ASE is committed to working across the field of cardiovascular health to impact better patient care. We hope that by identifying synergies with groups like PCNA that have similar challenges and a different perspective, we can bridge gaps and build understandings for all practitioners.

LEARN MORE

ECHO VOL 11 | Issue 12


View Issue Larger | Download (PDF)

Congress Passes the CAROL Act

ASE would like to thank Congress for passage of the Cardiovascular Advances in Research and Opportunities Legacy (CAROL) Act (H.R. 1193/S. 1133). ASE was pleased to support this bipartisan legislation. Senators McConnell and Sinema introduced the Senate companion legislation to Congressman Barr’s House legislation, which will help heart patients through expanded research, education, and investments into valvular heart disease.ASE Advocacy

According to the CDC, valvular heart disease affects 2.5% of the U.S. population. As many as 11 million Americans are living with heart valve disease and, each year, five million additional Americans are diagnosed with it. The CAROL Act pledges the necessary investments in research and prevention to aid the millions of American lives affected by this disease. We thank leaders in the House and Senate for their partnership in getting this bill done.

We surpassed our GivingTuesday goal of $30,000—thank you so much!

The ASE Foundation is ecstatic to share that we have already surpassed our $30,000 fundraising goal! Thank you to the 109 donors who have contributed a total of $32,457.94 as of this afternoon.

Thank you for your support on GivingTuesday

We may have reached our goal, but we are not done! The Foundation is still accepting donations towards its GivingTuesday fundraiser until December 3, so if you have not already done so—it is not too late to donate! Every donation brings us closer to our 2022 Annual Appeal goal of $225,000.

An investment in the ASE Foundation is a testament of support in the future of cardiovascular ultrasound. Wherever your heart lies in our field, ASEF is making a difference. Show us #YourPriority with a donation to the initiative that most aligns with your passion. If you would like to make a donation to support a 2023 Global Outreach Travel Grant in memory of Greg Tatum, MD, FASE, please indicate that your donation is in his memory on the donation form.

100% of your donation will go toward charitable projects in 2023. Thank you for showing us that supporting the future of cardiovascular ultrasound is #YourPriority. Together we will continue to make a world of difference!

ECHO VOL 11 | Issue 11


View Issue Larger | Download (PDF)

Today is GivingTuesday—Help Us Raise $30,000!

GivingTuesday

Hello, and Happy GivingTuesday! The ASE Foundation is thrilled to participate in this global giving movement for the 10th year in a row. To mark the occasion, we set an ambitious fundraising goal of $30,000. Will you join the movement and help us reach our goal?

Follow this link to make your donation today. Your contribution to the ASE Foundation is an investment in the future of cardiovascular ultrasound and directly impacts the scope and success of our 2023 initiatives. No matter where your heart lies, the Foundation can support your passion and you can take pride in knowing that 100% of your donation goes back out into the field.

On this special day, we ask that you remember the ASE Foundation. Donations towards our $30,000 fundraising goal will be accepted through December 3. When you donate, let us know what inspired your contribution on social media. Remember to include #GivingTuesday and tag @ASE360.

November JASE-Enhancing Stress Echo

The November JASE includes, “Passive Leg Raise Stress Echocardiography in Severe Paradoxical Low-Flow, Low Gradient Aortic Stenosis,” from Drs. Buffle, Papadis, Boscolo Berto, Grani, Seiler, and de Marchi. Dr. de Marchi noted, “Stress echocardiography has been relying on dobutamine, also for patients with aortic stenosis. This study evaluates an increase in LV filling using passive leg raise in both, classical and paradoxical low-flow low-gradient aortic stenosis. It shows that adding leg raise to dobutamine increases the parameters we wish to stimulate in stress echocardiography.”

Two other clinical investigations also look at novel applications of stress echo. Additional clinical investigations explore optimum indexing of cardiac measurements, fetal echo prediction of postnatal obstruction in total anomalous pulmonary venous connection, cardiac function and pulmonary hemodynamics in infants with Down Syndrome, and echocardiographic imaging of myocardial scar, with an accompanying editorial, “Detecting Scar in Echocardiography: Has the Power Shifted?” from Drs. Appadurai and Thomas. A review article, which offers CME, explores tricuspid regurgitation related to cardiac implantable electronic devices. A group of robust brief research communication on validation of alternative left atrial indexation methods in obesity, development of a new technique for ultrasound imaging of the innominate vein and the venous angle, local arterial stiffness assessment, and assessment of diastolic energy loss in hypertensives versus controls and thought-provoking correspondence round out the issue.

The President’s Message from Stephen H. Little, MD, FASE, illustrates how ASE is making sure that it is preparing, planning, and prioritizing to be a leader in how Societies grapple with all of the digital data that is part of general society and of course, echocardiography. The continuing education and meeting calendar outlines a multitude of learning options near and far.